IRELAND’S ORTHOPAEDICS MARKET IS SET TO EMBRACE ‘INNOVATIVE AND EXCITING’ TREATMENT TO HELP EASE PAIN CAUSED BY KNEE OSTEOARTHRITIS
Arthrosamid is a polyacrylamide hydrogel developed by Contura International Ltd. as a long-lasting intra-articular injection approved in Europe for the treatment of knee osteoarthritis (OA). The treatment has the potential to change the present care pathway for managing osteoarthritis, which affects around one in four adults in Ireland aged over 601 (over 400,000 people)2 and […]
A NEW CLASS OF “INJECTABLES” TO ENTER ITALY’S ORTHOPAEDIC MARKET THANKS TO A DYNAMIC PARTNERSHIP WITH MEDICAL MANUFACTURERS CONTURA ORTHOPAEDICS
Arthrosamid is a polyacrylamide hydrogel developed by Contura International Ltd. as a long-lasting intra-articular injection, approved in Europe to treat knee osteoarthritis (OA). The treatment has the potential to change the present care pathway for managing OA, which affects around 8,6 million people in Italy1…current treatments are not long-lasting or involve invasive knee replacement surgery. […]
PATIENTS GAIN ACCESS TO INNOVATIVE NEW PROCEDURE FOR TREATING KNEE OSTEOARTHRITIS AS HCA UK PARTNERS WITH CONTURA ORTHOPAEDICS
London, September 2022; Contura Orthopaedics Ltd is pleased to announce that a major hospital group has signed up to Arthrosamid, allowing clinicians to offer this novel procedure to its patients in London and across the UK. musculoskeletal disorders in addition to sporting injuries and complaints at its state-of-the-art facility located on Tottenham Court Road in […]
